Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.83 billion. The enterprise value is $1.93 billion.
Important Dates
The last earnings date was Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 104.79 million shares outstanding. The number of shares has decreased by -7.19% in one year.
| Current Share Class | 104.79M |
| Shares Outstanding | 104.79M |
| Shares Change (YoY) | -7.19% |
| Shares Change (QoQ) | +4.55% |
| Owned by Insiders (%) | 5.20% |
| Owned by Institutions (%) | 82.06% |
| Float | 91.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.37 |
| PS Ratio | 0.83 |
| Forward PS | 1.16 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.69 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.91.
| Current Ratio | 2.32 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -456.15 |
Financial Efficiency
Return on equity (ROE) is -53.47% and return on invested capital (ROIC) is -44.29%.
| Return on Equity (ROE) | -53.47% |
| Return on Assets (ROA) | -11.24% |
| Return on Invested Capital (ROIC) | -44.29% |
| Return on Capital Employed (ROCE) | -29.18% |
| Weighted Average Cost of Capital (WACC) | 4.12% |
| Revenue Per Employee | $1.60M |
| Profits Per Employee | -$519,978 |
| Employee Count | 1,372 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.84 |
Taxes
In the past 12 months, SRPT has paid $11.19 million in taxes.
| Income Tax | 11.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.68% in the last 52 weeks. The beta is 0.39, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -83.68% |
| 50-Day Moving Average | 20.57 |
| 200-Day Moving Average | 21.82 |
| Relative Strength Index (RSI) | 39.24 |
| Average Volume (20 Days) | 2,377,215 |
Short Selling Information
The latest short interest is 22.22 million, so 21.21% of the outstanding shares have been sold short.
| Short Interest | 22.22M |
| Short Previous Month | 21.28M |
| Short % of Shares Out | 21.21% |
| Short % of Float | 24.26% |
| Short Ratio (days to cover) | 7.25 |
Income Statement
In the last 12 months, SRPT had revenue of $2.20 billion and -$713.41 million in losses. Loss per share was -$7.13.
| Revenue | 2.20B |
| Gross Profit | -163.43M |
| Operating Income | -657.77M |
| Pretax Income | -702.23M |
| Net Income | -713.41M |
| EBITDA | -605.41M |
| EBIT | -657.77M |
| Loss Per Share | -$7.13 |
Full Income StatementBalance Sheet
The company has $939.65 million in cash and $1.04 billion in debt, with a net cash position of -$100.10 million or -$0.96 per share.
| Cash & Cash Equivalents | 939.65M |
| Total Debt | 1.04B |
| Net Cash | -100.10M |
| Net Cash Per Share | -$0.96 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 10.87 |
| Working Capital | 1.44B |
Full Balance SheetMargins
Gross margin is -7.43%, with operating and profit margins of -29.92% and -32.45%.
| Gross Margin | -7.43% |
| Operating Margin | -29.92% |
| Pretax Margin | -31.94% |
| Profit Margin | -32.45% |
| EBITDA Margin | -27.54% |
| EBIT Margin | -29.92% |
| FCF Margin | n/a |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.19% |
| Shareholder Yield | 7.19% |
| Earnings Yield | -39.02% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SRPT is $25.76, which is 47.62% higher than the current price. The consensus rating is "Hold".
| Price Target | $25.76 |
| Price Target Difference | 47.62% |
| Analyst Consensus | Hold |
| Analyst Count | 28 |
| Revenue Growth Forecast (5Y) | -4.28% |
| EPS Growth Forecast (5Y) | 0.81% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of -0.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.3 |
| Piotroski F-Score | 2 |
